NEW HAVEN, Conn., Jan. 13, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Joseph Truitt, Senior Vice President of Business Development and Chief Commercial Officer of Achillion, will present at the upcoming Noble Financial Capital Markets' Eight Annual Equity Conference on Wednesday, January 18, 2011 at 9:30 a.m. EST at the Hard Rock Hotel in Hollywood, FL.
